-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCON ANNOUNCES U.S. COMMERCIAL LAUNCH OF YESAFILI™, A BIOSIMILAR TO REGENERON’S EYLEA® 2 MG

Reuters·08/03/2026 11:05:00

Please log in to view news